Public health challenges and prospects for malaria control and elimination

Nature Medicine

Volumn 19, Issue 2, 2013, Pages 150-155

  Alonso, Pedro L ^a,b   Tanner, Marcel ^c,d  

^a CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^b Ministério de Saúde   (Mozambique)

^c SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^d UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ; MALARIA VACCINE; NITD 609; OZ 439; PYRIMETHAMINE PLUS SULFADOXINE; TAFENOQUINE; UNCLASSIFIED DRUG;

AFRICA SOUTH OF THE SAHARA; ANTIMALARIAL DRUG RESISTANCE; BED NET; CENTRAL AFRICA; ECONOMIC DEVELOPMENT; FINANCIAL MANAGEMENT; FUNDING; HEALTH CARE SYSTEM; IMMUNIZATION; INSECTICIDE RESISTANCE; MALARIA; MALARIA CONTROL; MANAGEMENT; MORTALITY; PARASITE TRANSMISSION; POLITICS; POVERTY; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; REVIEW; URBANIZATION;

COST OF ILLNESS; DRUG RESISTANCE; HUMANS; MALARIA; MALARIA VACCINES; PUBLIC HEALTH;

EID: 84873551273     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.3077     Document Type: Review

References (40)

1. World Health Organization. World malaria report 2012. World Health Organization http://www.who.int/malaria/publications/world-malaria-report-2012/ wmr2012-full-report.pdf (2012
2. Roll Back Malaria Partnership. The global malaria action plan. World Health Organization http://www.rbm.who.int/gmap/gmap.pdf (2008
3. Roll Back Malaria Partnership. Refined/updated GMAP objectives, targets, milestones and priorities beyond 2011. Roll Back Malaria http://www.rbm.who.int/ gmap/gmap2011update.pdf (2011
4. Moran, M. et al. Neglected disease research and development: Is innovation under threat? Policy Cures http://www.hst.org.za/sites/default/files/ g-finder-2011.pdf (2011
5. Alonso, P.L. et al. A research agenda to underpin malaria eradication. PLoS Med. 8, e1000406 (2011
6. Murray, C.J.L. et al. Global malaria mortality between 1980 and 2010: A systematic analysis. Lancet 379, 413-431 (2012
7. Guerra, C.A. et al. The limits and intensity of Plasmodium falciparum transmission: Implications for malaria control and elimination worldwide. PLoS Med. 5, e38 (2008
8. Okiro, E.A. et al. The decline in pediatric malaria admissions on the coast of Kenya. Malar. J. 6, 151 (2007
9. Schellenberg, D. et al. The changing epidemiology of malaria in Ifakara Town, Southern Tanzania. Trop. Med. Int. Health 9, 68-76 (2004 (Pubitemid 38178014)
10. Bhattarai, A. et al. Impact of artemesinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar. PLoS Med. 4, e309 (2007
11. Sharp, B.L. et al. Seven years of regional malaria control collaboration- Mozambique, South Africa and Swaziland. Am. J. Trop. Med. Hyg. 76, 42-47 (2007 (Pubitemid 351627800)
12. Rodrigues, A. et al. Changing pattern of malaria in Bissau, Guinea Bissau. Trop. Med. Int. Health 13, 410-417 (2008
13. Nyarango, P.M. et al. A steep decline of malaria morbidity and mortality trends in Eritrea between 2000 and 2004: The effect of combination of control methods. Malar. J. 5, 33 (2006
14. World Health Organization. Global plan for artemisinin resistance containment. World Health Organization http://www.who.int/malaria/publications/ atoz/artemisinin-resistance-containment-2011.pdf (2011
15. Charman, S.A. et al. Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria. Proc. Natl. Acad. Sci. USA 108, 4400-4405 (2011
16. Rottmann, M. et al. Spiroindolones, a potent compound class for the treatment of malaria. Science 329, 1175-1180 (2010
17. The malERA Consultative Group on Drugs. A research agenda for malaria eradication: Drugs. PLoS Med. 8, e1000402 (2011
18. Davies, T.E., O'Reilly, A.O., Field, L.M., Wallace, B. & Williamson, M.S. Knockdown resistance to DDT and pyrethroids: From target-site mutations to molecular modelling. Pest Manag. Sci. 64, 1126-1130 (2008
19. Matambo, T.S. et al. Insecticide resistance in the malaria mosquito Anopheles arabiensis and association with the kdr mutation. Med. Vet. Entomol. 21, 97-102 (2007 (Pubitemid 46439449)
20. Enayati, A. & Hemingway, J. Malaria management: Past, present, and future. Annu. Rev. Entomol. 55, 569-591 (2010
21. World Health Organization. Global plan for insecticide resistance management in malaria vectors. World Health Organization http://whqlibdoc.who. int/publications/2012/9789241564472-eng.pdf (2012
22. The malERA Consultative Group on Vector Control. A research agenda for malaria eradication: Vector control. PLoS Med. 8, e1000401 (2011
23. World Health Organization. Guidelines for the treatment of malaria, second edition. World Health Organization http://whqlibdoc.who.int/publications/ 2010/9789241547925-eng.pdf (2010
24. D'Acremont, V. et al. Reduction of anti-malarial consumption after rapid diagnostic tests implementation in Dar es Salaam: A before-after and cluster randomized controlled study. Malar. J. 10, 107 (2011
25. The malERA Consultative Group on Diagnoses and Diagnostics. A research agenda for malaria eradication: Diagnoses and diagnostics. PLoS Med. 8, e1000396 (2011
26. Aponte, J.J. et al. Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: A pooled analysis of six randomised, placebo-controlled trials. Lancet 374, 1533-1542 (2009
27. Greenwood, B.M. Comparison of two strategies for control of malaria within a primary health care programme in The Gambia. Lancet 1, 1121-1127 (1988
28. WHO/GMP Technical Expert Group on Preventive Chemotherapy. Report of the technical consultation on seasonal malaria chemoprevention (SMC). World Health Organization http://www.who.int/malaria/publications/atoz/smc-report-teg- meetingmay2011.pdf (2011
29. WHO Global Malaria Programme. WHO policy recommendation: Seasonal malaria chemoprevention (SMC) for Plasmodium falciparum malaria control in highly seasonal transmission areas of the Sahel sub-region in Africa. World Health Organization http://www.who.int/malaria/publications/atoz/smc-policy- recommendation-en-032012.pdf (2012
30. Alonso, P.L. et al. Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: Randomised controlled trial. Lancet 364, 1411-1420 (2004 (Pubitemid 39370716)
31. Aponte, J.J. et al. Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: A double blind randomised controlled phase I/IIb trial. Lancet 370, 1543-1551 (2007 (Pubitemid 350018877)
32. Abdulla, S. et al. Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants. N. Engl. J. Med. 359, 2533-2544 (2008
33. RTS,S Clinical Trials Partnership. et al. First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N. Engl. J. Med. 365, 1863-1875 (2011
34. RTS,S Clinical Trials Partnership. et al. A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N. Engl. J. Med. 367, 2284-2295 (2012
35. Aide, P. et al. Safety, immunogenicity and duration of protection of the RTS,S/AS02D malaria vaccine: One year follow-up of a randomized controlled phase I/IIb trial. PLoS ONE 5, e13838 (2010
36. Guinovart, C. et al. Insights into long-lasting protection induced by RTS,S/AS02A malaria vaccine: Further results from a phase IIb trial in Mozambican children. PLoS ONE 4, e5165 (2009
37. Hoffman, S.L. et al. Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria. Hum. Vaccin. 6, 97-106 (2010
38. Cech, P.G. et al. Virosome-formulated Plasmodium falciparum AMA-1 & CSP derived peptides as malaria vaccine: Randomized phase 1b trial in semi-immune adults & children. PLoS ONE 6, e22273 (2011
39. Reyes-Sandoval, A. et al. Prime-boost immunization with adenoviral and modified vaccinia virus ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses. Infect. Immun. 78, 142-153 (2010
40. Mendis, K., Sina, B.J., Marchesini, P. & Carter, R. The neglected burden of Plasmodium vivax malaria. Am. J. Trop. Med. Hyg. 64, 97-106 (2001 (Pubitemid 32552576)